Adage Capital Partners Gp, L.L.C. Janux Therapeutics, Inc. Transaction History

Adage Capital Partners Gp, L.L.C.

$59.7 Billion
Q3 2025

A detailed history of Adage Capital Partners Gp, L.L.C. transactions in Janux Therapeutics, Inc. stock. As of the latest transaction made, Adage Capital Partners Gp, L.L.C. holds 2,775,000 shares of JANX stock, worth $81.3 Million. This represents 0.11% of its overall portfolio holdings.

Number of Shares

2,775,000

Previous 2,525,000 9.9%

Holding current value

$81.3 Million

Previous $58.3 Million 16.28%

% of portfolio

0.11%

Previous 0.1%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 14, 2025	BUY	$21.77 - $27.75 $5.44 Million - $6.94 Million	250,000 Added 9.9%	2,775,000 $67.8 Million
Q2 2025 Aug 14, 2025	SELL	$22.62 - $33.2 $25.6 Million - $37.5 Million	-1,129,574 Reduced 30.91%	2,525,000 $58.3 Million
Q1 2025 May 15, 2025	BUY	$27.0 - $57.81 $16 Million - $34.3 Million	592,824 Added 19.36%	3,654,574 $98.7 Million
Q4 2024 Feb 14, 2025	BUY	$40.18 - $66.83 $39.6 Million - $65.9 Million	986,750 Added 47.55%	3,061,750 $164 Million
Q3 2024 Nov 14, 2024	SELL	$35.29 - $50.26 $8.92 Million - $12.7 Million	-252,896 Reduced 10.86%	2,075,000 $94.3 Million
Q2 2024 Aug 14, 2024	SELL	$35.12 - $64.78 $15.7 Million - $29 Million	-447,776 Reduced 16.13%	2,327,896 $97.5 Million
Q1 2024 May 15, 2024	BUY	$7.93 - $49.75 $11.3 Million - $70.7 Million	1,420,197 Added 104.77%	2,775,672 $105 Million
Q4 2023 Feb 14, 2024	BUY	$5.85 - $11.7 $1.2 Million - $2.4 Million	205,475 Added 17.87%	1,355,475 $14.5 Million
Q3 2023 Nov 14, 2023	BUY	$9.56 - $14.0 $2.39 Million - $3.5 Million	250,000 Added 27.78%	1,150,000 $11.6 Million
Q1 2023 May 15, 2023	BUY	$11.25 - $22.21 $2.24 Million - $4.42 Million	198,934 Added 28.38%	900,000 $10.9 Million
Q4 2022 Feb 14, 2023	BUY	$11.1 - $18.26 $3.34 Million - $5.5 Million	301,066 Added 75.27%	701,066 $9.23 Million
Q3 2021 Nov 15, 2021	SELL	$20.7 - $34.69 $1.04 Million - $1.73 Million	-50,000 Reduced 11.11%	400,000 $8.65 Million
Q2 2021 Aug 16, 2021	BUY	$18.58 - $25.37 $8.36 Million - $11.4 Million	450,000 New	450,000 $11.2 Million

Others Institutions Holding JANX

# of Institutions

182

Shares Held

55M

Call Options Held

598K

Put Options Held

212K

View Full List

About Janux Therapeutics, Inc.

Ticker JANX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,663,000
Market Cap $1.22B
Description
Janux Therapeutics, Inc., a biopharmaceutical company, develops therapeutics based on proprietary Tumor Activated T Cell Engager (TRACTr) platform technology to treat patients suffering from cancer. The company's lead TRACTr product candidates that are in preclinical or discovery stage target prostate-specific membrane antigen, epidermal growth ...

More about JANX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Adage Capital Partners Gp, L.L.C., based on Form 13F filings with the SEC.

News

Stay updated on Adage Capital Partners Gp, L.L.C. with notifications on news.

Account

Adage Capital Partners Gp, L.L.C. Janux Therapeutics, Inc. Transaction History